|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Details of Buy-Back
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Additional Explanations
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Pursuant to share buyback transactions initiated with the resolution of the Board of Directors of MLP Sağlık Hizmetleri A.Ş. dated May 25, 2022, On June 7, 2022, MPARK shares with TL 40,000 nominal value were repurchased within a price range of TL 35.40 – TL 36.10 (weighted average TL 35.64) per share on Istanbul Stock Exchange by MLP Sağlık Hizmetleri A.Ş., As of June 7, 2022, total nominal value of repurchased shares have become TL 510,000 which represents 0.2451% of the share capital, following the transactions. This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||